A novel splice‐site mutation in CHMP2B associated with frontotemporal dementia: The first report from China and literature review
Molecular Genetics & Genomic Medicine · 2023
DOI: 10.1002/mgg3.2222 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Genetics & Genomic Medicine, 2023. Verfasst von Chang Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Second Hospital of Hebei Medical University, Shijiazhuang, China. Hauptthemen laut MEDLINE: Frontotemporal Dementia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Demenz
Abstract (Originalsprache)
Background
Frontotemporal dementia (FTD) has genetic heterogeneity, and the endosomal ESCRTIII‐complex subunit CHMP2B variant is a rare cause of FTD. The mutations in CHMP2B were first identified in a large Danish pedigree with autosomal dominant FTD, and have also been found in several individuals from Belgium, France, the United States, and Türkiye. In the Chinese population, cases of CHMP2B variant‐associated FTD have never been reported.
Methods
The spectrum of clinical symptoms and the genetic analysis of the presented patient were identified and investigated. Besides this case, we assessed previously reported cases with CHMP2B gene mutations.
Results
This study presents a Chinese patient harboring a novel heterozygous A‐to‐T variant (NM_014043:c.532‐2A>T) in CHMP2B with a phenotype compatible with FTD. Although previous reports suggested cases of CHMP2B variant‐associated FTD initially presented with personality changes and stereotypical movements at the age of 50, this case was characterized by psychosis involving delusion of persecution, auditory hallucination, and suspiciousness at the earlier onset age of 44. Minigene splicing assay revealed that the splice‐site variant could result in the retention of intron 5.
Conclusion
This is the first case of CHMP2B variant‐associated FTD reported in the Chinese population. The novel c.532‐2A>T variant in the acceptor splice site of exon 6 retaining intron 5 was predicted to cause truncated protein and protein conformation changes. This discovery may expand the genetic and phenotypic spectrum of CHMP2B variant‐associated FTD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Second Hospital of Hebei Medical University, Shijiazhuang, China.
- Neurological Laboratory of Hebei Province, Shijiazhuang, China.
ORCID-Profile: Shan Wang
Zitieren
APA
Li, C., Wen, Y., Zhao, M., Wang, Y., Li, P., Wang, L., & Wang, S. (2023). A novel splice‐site mutation in CHMP2B associated with frontotemporal dementia: The first report from China and literature review. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.2222
Vancouver
Li C, Wen Y, Zhao M, Wang Y, Li P, Wang L, et al. A novel splice‐site mutation in CHMP2B associated with frontotemporal dementia: The first report from China and literature review. Molecular Genetics & Genomic Medicine. 2023. doi:10.1002/mgg3.2222
BibTeX
@article{Li2023,
author = {Li, Chang and Wen, Ya and Zhao, Mengqiu and Wang, Yaye and Li, Ping and Wang, Liang and Wang, Shan},
title = {A novel splice‐site mutation in CHMP2B associated with frontotemporal dementia: The first report from China and literature review},
journal = {Molecular Genetics & Genomic Medicine},
year = {2023},
doi = {10.1002/mgg3.2222}
}
EUVIMED